What if death was not the end? What if, instead of saying our final goodbyes to loved ones, we could freeze their bodies and bring them back to life once medical technology has advanced enough to cure their fatal illnesses? This is the mission of Tomorrow Biostasis, a Berlin-based startup that specializes in cryopreservation.
Cryopreservation, also known as biostasis or cryonics, is the process of preserving a human body (or brain) in a state of suspended animation, with the hope that it can be revived in the future when medical technology has advanced enough to treat the original cause of death. This may seem like science fiction, but it is a legitimate scientific procedure, and Tomorrow Biostasis is one of the few companies in the world that offers this service.
Dr Emil Kendziorra, co-founder and CEO of Tomorrow Biostasis explained that the goal of cryopreservation is to extend life by preserving the body until a cure can be found for the original illness. He emphasized that cryopreservation is not a form of immortality, but rather a way to give people a second chance at life.
]]>This American cryonics facility has preserved “patients” in liquid nitrogen-filled tanks until a future date when technology allows them to be thawed.
]]>This week our guest is business and technology reporter, Peter Ward. Earlier this year, Peter released his book The Price of Immortality: The Race to Live Forever, where he investigates the many movements and organizations that are seeking to extend human life, from the Church of Perpetual Life in Florida, to some of the biggest tech giants in Silicon Valley.
In this episode, we explore Peter’s findings, which takes us on a tour from cryonics to mind uploading, from supplements to gene editing, and much more. Along the way, we discuss the details of how one might actually achieve immortality, the details of senescent cells and telomeres, whether it’s better to live healthy than to live long, the scams and failures that seem to dominate the space, as well as the efforts that seem most promising.
Find Peter’s work on PenguinRandomHouse.com or follow him at twitter.com/PeterWardJourno.
Host: steven parton — linkedin / twitter.
Music by: Amine el Filali.
]]>Life is short, but Tomorrow Bio explains how cryonics is a good option that can offer more time for your lifespan. Check out how below!
]]>You can arrange for automatic PayPal payment of Yearly Membership Dues on a Quarterly or Yearly basis AFTER you have filled-in and submitted a membership application and paid the initiation fee which have been received and approved. (You can pay the initiation fee by going to PayPal. From the top menu, select “Personal Send and receive Send Money.” Enter for the email address and make your payment of $75.) Note that when arranging for automatic Quarterly or Yearly payment, the first Quarterly or Yearly payment is made IMMEDIATELY upon arranging for automatic payment.
]]>This is a followup trial result to the first trial that reported 2.5 years of epigenetic age reversal This has interesting reports from the actual patients about how they feel and the changes it made to them. After the first trial I sent an email to see if I could do this but I have IBS which Fahy said would disqualify me.
Dr. Greg Fahy gives an update on the TRIIM-X clinical trial at EARD 2022.
The TRIIM-X clinical trial aims to understand how to create a personalized thymus regeneration regimen. By regenerating the thymus, the researchers hope to be able to prevent or reverse certain aspects of immune system aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
https://www.lifespan.io.
https://www.facebook.com/lifespanio.
https://www.instagram.com/lifespan.io/
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.
Dr. Fahy is the Chief Scientific Officer and co-founder of Intervene Immune, a biotech company researching rejuvenation of the immune system, particularly the thymus. He designed and led the TRIIM trial, published the first report of thymus regeneration in a normal human, and granted patents on methods for and applications of human thymus regeneration. Before his time at 21st Century Medicine, where he is the Executive Director and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross.
Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.
The annual Ending Age-Related Diseases (EARD) conference by Lifespan.io brings together longevity thought leaders together to exchange research reports, inspire and get inspired with new ideas, find collaborators, supporters, and mentors.
]]>2022 https://cryonics.org/wp-content/uploads/2022/11/CI_NEWS-2022-03.pdf.
This issue features:
* President’s Report — New Science Advisory Board.
* 2022 AGM Photos.
* Board of Directors Winners.
* Scale Model CI Cryostats for Sale.
* Cryonics Survey.
* Robert Ettinger’s YOUNIVERSE — Chapter 5
* Latest Cryonics & Life Extension News from Around the Web.
Although my plan is to live forever (or at least, a very long time, societal and natural disasters willing) I know many people in the life-extension community are signed up with a cryonics provider, as a plan B, in case they don’t live long enough to welcome the rejuvenation revolution.
A lot has been written to explain how the people are stored, usually accompanied by a picture of the gleaming liquid nitrogen cooled Dewar flasks, along with the ethical questions of the procedure. However, the journey to the semi-final resting place is often overlooked.
To explore how someone who has signed up to a cryonics program makes that transition, I attended one of the regular cryonics demonstration and training sessions put on by Cryonics UK. It turns out there are 4 key stages in the process – standby, initial cool down, perfusion and transportation.
]]>Do we need a new criteria for death, that covers the technicalities around neuro preservation, issues of legal identity upon reanimation and an approach to rehabilitation? What are the misunderstandings or misinformation that surround transhumanism and endeavour to make the distinction between transhumanism and technocracy? Should we be worried about the wrong headedness of The Population Bomb, climate catastrophism and the fashionability of long termism?
Today, I speak with Max More. As some of you may already know, Max is considered to be the founder of modern transhumanism, a philosopher and futurist who writes extensively on technology and humanity. He’s also currently ambassador and President Emeritus at Alcor Life Extension Foundation, having served almost 10 years as President and CEO there, and having been its 67th member. His 1995 University of Southern California doctoral dissertation, ‘The diachronic self identity continuity and transformation’, examined several issues that concern transhumanists, including the nature of death. He is the Co-editor of Rhe Transhumanist Reader, and he’s written many articles on transhumanism and extropianism, including the 1990 essay, ‘Transhumanism: toward a futurist philosophy’, in which he introduced the term transhumanism, in its modern sense.
This episode of The Future of You covers:
]]>Over the years, this FAQ has been updated to provide a substantial account of transhumanism. Extropy Institute (ExI) was a source of information for the first version of the Transhumanist FAQ, version 1.0 in the 1990s. The Transhumanist Manifesto, conceived by Natasha Vita-More in 1983 and revised in 1998–2020 to include advances of the growing worldview, was published in the CD placed onboard the Cassini-Huygens spacecraft in its mission to Saturn.
Humanity+, also known as WTA, adopted the FAQ in 2001 and Nick Bostrom added substantial information about future scenarios. With the contributions of close to hundred people from ExI, Aleph, DeTrans, Transcedo, WTA, and the UK Transhumanist Association, new material has been added and many old sections have been substantially reworked. In the preparation of version 2.0, the following people have been especially helpful: Eliezer Yudkowsky, who provided editorial assistance with comments on particular issues of substance; Dale Carrico who proofread the first half of the text; and Michael LaTorra who did the same for the second half; and “Reason” who then went over the whole document again, as did Frank Forman, and Sarah Banks Forman. Useful comments of either substance or form have also been contributed by (in alphabetical order): Michael Anissimov, Samantha Atkins, Milan Cirkovic, José Luis Cordeiro, George Dvorsky, James Hughes, G.E.
]]>